CanadianCannabisWire LimeLight of The MONTH is
 

RYAH Group Inc.
(CSE: RYAH)

RYAH Group Inc. (CSE: RYAH) is a leading digital health care analytics and technology company with a mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments. Through the company’s IoT dose-measuring devices and AI analytics, RYAH is reshaping understanding of the value of devices combined with data, to positively impact the future treatment of patients for various medical conditions.

The company is a leading developer of dose-measuring IoT devices connected with its turn-key platform designed to aggregate and correlate HIPPA-compliant data, suitable to all participants in the patient treatment cycle. The company also specializes in customized, fully integrated, mobile applications and APIs, specifically designed to meet the needs of clinics, clinical trials, government and university research centers, for experimentation and treatment validation – significantly reducing variations in patient-related trials. RYAH unlocks data in the complete therapeutic plant lifecycle – from seed to consumption.

Since it began developing and commercializing its smart inhaler solution in 2018, the company has evolved a complete IoT device and data analytics platform that includes multiple delivery mechanisms, designed to capture anonymous patient dosing and feedback, combined with detailed strain analytics, enabling customized dosing regiments. The company has secured numerous partnerships across the globe, including establishing a footprint in the UK, USA, Australia and Canada, and it has closed several deals in the European Union, as well. The company’s Smart-Inhaler has been selected as the dose-measurement, dose-control and data analytics platform for a UK pain management study and one of the world’s most ambitious and largest clinical trials ever to be conducted in cannabis.

Investment Considerations

• RYAH Group is a technological leader in the plant-based treatment market with its unique combination of proprietary IoT devices and data analytics, supported by patented AI technology.
• The company’s products pair a growing ecosystem of therapeutic plants with top-rated apps, devices and services.
• RYAH offers a complete remote dosage delivery and dose-monitoring platform based on data-driven analytics supported by prescribing doctors and their patients.
• The company is finalizing its anticipated listing on the Canadian Securities Exchange.
• RYAH holds a unique position on the $100.3 billion medical plant market, with the potential to capture footholds in both the IoT and Data Intelligence industries.

Receive SMS Text Alerts from CanadianCannabisWire

Text "CCWIRE" to 844-397-5787

(US Mobile Phones Only)

Recent Coverage
 

InvestorNewsBreaks - RYAH Group Inc. (CSE: RYAH) Names New Director, CEO

April 12, 2022 12:00 PM

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has announced that its board of directors has nominated Dr. David R. Richards, PhD, FIoD, FRSA, CPsych, as a new director and the company’s chief executive officer. Richards comes to the new positions with impressive experience, including serving in leadership roles at Nortel Networks' GM Global Data; GM Global Supercarriers; GM UK Switching; and Global ThinkQuest Champion at Oracle's Education Foundation. He has served as CEO of Ellis Jones Solicitors, executive director of business development and marketing at AECC University College, senior vice president and director of the Dorset Chamber of Industry and Commerce and board director of the West Hants Lawn and Tennis Club. An author, independent consultant and advisor, Richards cofounded the MIT Innovation Lab and is a lifetime member of the think tank, engaging with global innovation leaders at institutions such as NASA, UNDP, Nortel, 3M, Pitney Bowes and others in sharing best practices and key insights enabling substantially improved returns on investments in innovation initiatives. The nomination is subject to approval by the Canadian Securities Exchange. “I am extremely excited to be joining RYAH, which has a strong team, board and IP portfolio, poised to address many imminent and exciting challenges and opportunities in ways that will benefit humanity and make the world a better place, driving the company's growth, value and success,” said RYAH Group newly appointed CEO David R. Richards in the press release.

About CanadianCannabisWire (CNW)

CanadianCannabisWire (CCW) is a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging a professional team of journalists and writers, CCW introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network of over 5,000 key distribution outlets. Cutting through information overload, CCW's innovative and proprietary systems clearly and succinctly deliver its clients much needed visibility, recognition and brand awareness. CCW is where news, content and information converge.